alexa What Is The Future Of Alcohol Use Disorder Treatment | 30454
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

What is the future of alcohol use disorder treatment

4th International Conference and Exhibition on Addiction Research & Therapy

Jason Connor

Keynote: J Addict Res Ther

DOI: 10.4172/2155-6105.S1.020

In spite of advances in the treatment of Alcohol Use Disorders (AUDs), short-term treatment outcomes remain modest and longer term prognosis poor. This keynote address argues cross-disciplinary research is essential to the future of Alcohol Use Disorder (AUD) treatment. Four empirical studies are presented as examples, covering research across disciplines of clinical psychology, machine learning, clinical pharmacology and molecular biology that extend knowledge of the etiology and treatment of AUDs. Study 1: Clinical trial that compared (non-linear statistical) machine learning approaches against expert clinical judgment in predicting treatment outcome of a 3 month Cognitive Behavioural Treatment (CBT) AUD treatment program. Study 2: Clinical trial that examined the contribution of adjunctive pharmacotherapy (anti-craving and relapse-prevention agents) to CBT in AUD treatment. Study 3: Cross-sectional and prospective studies that examine the relationship between severity phenotypes and psychological and genetic mechanisms known to be associated with alcohol dependence. Study 4: Preliminary data from a new clinical trial which ‘personalizes’ alcohol dependence treatment on the basis of psychological and genetic risk. To advance outcomes in AUD treatment, addiction science must be more responsive to research design technologies and evidence-based findings from allied disciplines.

Jason Connor is a Principal Research Fellow in the Centre for Youth Substance Abuse Research at The University of Queensland, Australia. He also holds a National Health and Medical Research Council (NH & MRC) of Australia Fellowship. He is a clinical psychologist by training and a Fellow of the Australian Psychological Society (APS). Since moving from full-time clinical practice to academia (PhD, 2002), he has published 125 peer reviewed papers in the leading addiction (e.g. Addiction) and medical journals (e.g. Lancet). He has received over $8 AUD million in funding.